Anti-MTA2/PID antibody [EPR8537(2)]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(4 Publications)
Rabbit Recombinant Monoclonal MTA2/PID antibody. Suitable for IHC-P, WB, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 4 publications.
View Alternative Names
MTA1L1, PID, MTA2, Metastasis-associated protein MTA2, Metastasis-associated 1-like 1, p53 target protein in deacetylase complex, MTA1-L1 protein
- WB
Supplier Data
Western blot - Anti-MTA2/PID antibody [EPR8537(2)] (AB171073)
All lanes:
Western blot - Anti-MTA2/PID antibody [EPR8537(2)] (ab171073) at 1/1000 dilution
Lane 1:
MCF7 cell lysate at 10 µg
Lane 2:
HeLa cell lysate at 10 µg
Lane 3:
SW480 cell lysate at 10 µg
Predicted band size: 75 kDa
false
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MTA2/PID antibody [EPR8537(2)] (AB171073)
Immunohistochemical analysis of paraffin-embedded Human colonic carcinoma tissue labeling MTA2/PID with ab171073 at 1/50 dilution.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MTA2/PID antibody [EPR8537(2)] (AB171073)
Immunohistochemical analysis of paraffin-embedded Human kidney tissue labeling MTA2/PID with ab171073 at 1/50 dilution.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-MTA2/PID antibody [EPR8537(2)] (AB171073)
Immunofluorescent staining of HeLa cells labeling MTA2/PID with ab171073 at 1/250 dilution.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-MTA2/PID antibody [EPR8537(2)] (AB171073)
Intracellular flow cytometric analysis of permeabilized Hela cells labeling MTA2/PID with ab171073 at 1/100 dilution (red)or a rabbit IgG negative (green).
Related conjugates and formulations (1)
-
Anti-MTA2/PID antibody [EPR8537(2)] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
MTA2 influences the suppression and activation of gene transcription. It acts as an integral part of the NuRD complex which combines chromatin remodeling and histone deacetylase activities. Through this role MTA2 helps control cellular differentiation proliferation and development. By modulating epigenetic states MTA2 can impact cellular responses to external stimuli helping cells adapt to changes in their environment.
Pathways
MTA2 engages in cellular signaling pathways including the Notch signaling and Wnt signaling pathways. These pathways are important for regulating cell fate decisions. MTA2 interacts with other proteins such as HDAC1 and HDAC2 to exert its influence on transcriptional repression and gene silencing. The NuRD complex of which MTA2 is part serves as a critical mediator in these pathways highlighting its importance in cellular homeostasis.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
The EMBO journal 42:e113448 PubMed37737560
2023
Applications
Unspecified application
Species
Unspecified reactive species
Biomolecules 13: PubMed37371463
2023
Applications
Unspecified application
Species
Unspecified reactive species
Pharmacology 106:573-587 PubMed34488224
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 11: PubMed31771219
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Associated Products
Alternative Product
Primary Antibodies
AB8106
Anti-MTA2/PID antibody
primary-antibodies
mta2-pid-antibody-ab8106
5
(2 reviews)
Alternative Product
Primary Antibodies
AB264123
Anti-MTA2/PID antibody
primary-antibodies
mta2-pid-antibody-ab264123
0
(0 reviews)
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com